美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

2倍做多NVO ETF-Defiance

11.75

-0.3019-2.51%

成交量：20.13萬

成交額：237.31萬

市值：3,075.77萬

市盈率：- -

高：12.15

開：12.14

低：11.70

收：12.05

52周最高：36.00

52周最低：9.23

股本：261.81萬

流通股本：261.81萬

量比：1.02

換手率：7.69%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

香港「兩倍做多」改"靈活槓桿"引質疑：就算正股回到高位，曾經的2被做多產品怕是再也回不去了

ETF日報 | 2倍做多Unity Software ETF漲逾31%；2倍做多彭博原油ETF升逾5%

BMO將諾和諾德目標價從45美元上調至47美元。

諾和諾德中國發布首份可持續發展案例集

諾和諾德公司：董事會成員、高管及關聯人士買賣諾和諾德公司股票。

「藥王」禮來替爾泊肽上半年大賣277億美元！諾和諾德也靠減重藥扛起大旗

红星资本局

從GLP-1先行者到被禮來反超，諾和諾德如何一步步丟掉減重藥領先優勢

老虎资讯综合

金錢語錄：諾和諾德CEO談併購

美銀首席執行官：公司每年為員工支出2.5億美元用於報銷GLP-1減重藥物

环球市场播报

相差百億美元！全球第一大藥王與第二大藥王銷售差距在拉大

二季度利潤亮眼股價卻下跌近6% 口服減重藥能撐起諾和諾德的中長期預期嗎？

每日经济新闻

諾和諾德：海牙法院針對 Ceban 下達臨時禁令。

諾和諾德贏得荷蘭法院禁令，保護患者免受未經批准的非法複方司美格魯肽鼻噴霧劑的侵害。

國產藥加速追趕減重明星賽道進入「群雄逐鹿」時代

諾和諾德首席執行官：相較於注射劑，口服版 Wegovy 的市場需求之高，讓我們愈發感到意外。

諾和諾德股價下跌6.8%，觸及盤中低點。

諾和諾德：目前美國市場索馬魯肽注射劑Wegovy的價格走勢與我們年初啓動定價時一致。

諾和諾德首席財務官表示：我們推進全公司轉型以實現80億丹麥克朗成本節約目標的進度，目前已超前於計劃。

諾和諾德股價跌勢擴大，目前跌幅已超5%，年初至今累計下跌10%。

諾和諾德(NVO.US)首席執行官：我們將在資本市場日上詳細介紹如何加速早期資產和早期科學的推進。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/NVOX/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":11.7481,"timestamp":1789583105284,"preClose":12.05,"halted":0,"volume":201305,"delay":0,"changeRate":-0.025053941908713677,"floatShares":2618100,"shares":2618100,"eps":0,"marketStatus":"交易中","change":-0.3019,"latestTime":"09-16 14:27:59 EDT","open":12.14,"high":12.15,"low":11.695,"amount":2373055.00458,"amplitude":0.037759,"askPrice":11.73,"askSize":300,"bidPrice":11.72,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":12.05,"sharesOutstanding":4098101,"nav":12.6,"aum":32988072.6,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":11.96,"preClose":12.05,"latestTime":"09:20 EDT","volume":13180,"amount":160697.55858,"timestamp":1789564823454,"change":-0.09,"changeRate":-0.007469,"amplitude":0.035685},"postHourTrading":{"tag":"盘后","latestPrice":12.08,"preClose":12.05,"latestTime":"19:30 EDT","volume":708,"amount":8545.8154,"timestamp":1789515006468,"change":0.03,"changeRate":0.00249,"amplitude":0.00249},"volumeRatio":1.020956,"impliedVol":0.6843,"impliedVolPercentile":0.228},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2618100,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.020956,"shares":2618100,"dividePrice":0,"high":12.15,"amplitude":0.037759,"preClose":12.05,"low":11.695,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":11.7481,"committee":0.142857,"eps":0,"divideRate":0,"volume":201305,"delay":0,"ttmEps":0,"open":12.14,"prevYearClose":21.89,"prevWeekClose":12.39,"prevMonthClose":13.84,"prevQuarterClose":16.05,"fiveDayClose":13.3,"twentyDayClose":14.205,"sixtyDayClose":14.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657695751","title":"香港「兩倍做多」改\"靈活槓桿\"引質疑：就算正股回到高位，曾經的2被做多產品怕是再也回不去了","url":"https://stock-news.laohu8.com/highlight/detail?id=2657695751","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657695751?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 12:03","pubTimestamp":1786075403,"startTime":"0","endTime":"0","summary":"8月7日，韩国股市7月份经历大跌，SK海力士、三星电子等遭遇大幅回撤。面对个股杠杆产品规模急剧扩张及市场剧烈波动，香港证监会宣布调整监管框架。尽管监管部门强调风险控制，但市场对于\"灵活杠杆\"机制仍存在不少质疑。更有人直呼：就算海力士正股回到高位，这只曾经的2被做多产品怕是再也回不去了！","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/07120358041514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SPYQ","XW","COZX","OSSL","SAA","NVOH","MVV","SPXU","IVV","DMAX","SPUU","UPRO","ETNG","NBIC","RGTC","TEUP","HIBL","SPXL","SIMX","VOO","NVOX","YSPY","MMAX","SH","SPYU","VRC","SPDN","LITC","SPYH","ONTX","ALA","SPXS","SPY","NVTC","SDS","BK4007","SPYM","SMAX","SSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127820441","title":"ETF日報 | 2倍做多Unity Software ETF漲逾31%；2倍做多彭博原油ETF升逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127820441","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127820441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 04:06","pubTimestamp":1786046792,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5Amana Developing World ETF上涨1.16%。Tradr 2X Long U Daily ETF上涨31.08%。Leverage Shares 2X Long MTSI Daily ETF上涨29.92%。该产品两倍做多射频与光通信芯片公司MACOM Technology Solutions，底层公司股价走强，杠杆机制放大当日涨幅。Tradr 2X Short NBIS Daily ETF上涨27.00%。2倍做多Figma ETF-Leverage Shares下跌29.90%。GraniteShares 2x Long NBIS Daily ETF下跌26.50%。纳指三倍做空ETF上涨1.07%。大宗商品ETF涨幅Top 5二倍做多彭博原油ETF上涨5.36%。行业指数ETF涨幅Top 5二倍做多能源ETF-Direxion上涨2.70%。债券ETF涨幅Top 5Invesco Senior Loan ETF上涨0.10%。Invesco Ultra Short Duration ETF上涨0.04%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XW","PXE","VOO","SPXS","IEO","DIA","FBZ","QQQX","WTIU","KGLD","NJUL","OILU","TZA","VTWO","YGLD","QDEC","OILD","FDN","GPIQ","QQQ","XPP","BK4554","FAAR","YXI","SIMX","SPYM","IGLD","DUG","IXC","WTID","DRIP","OSSL","TEUP","82822","DIG","BGLD","TQQQ","NVOX","UGL","YSPY","02823","APPC","SRS","GLL","CWEB","NERD","QID","IWM","QLD","NRGZ","IAUM","DBE","DDM","DBO","SMN","NVOH","SAA","GLDM","OILT","SPYQ","ASHS","HIBS","BK4609","LU1861559042.SGD","FLBR","HERO","DBC","AMEM","NBIG","OIH","PXJ","MTSG","NVTC","DGP","FLCH","LITC","OILK","BK4593","DWT","RWM","BK4077","BKLN","AAAU","USO","VDE","SDOW","SPXL","NBIC","YINN","MMAX","LU1861558580.USD","NOCT","APPX","BIL","BK4550","SHNY","UPRO","YANG","MINT","SMAX","SPUU","GSY","SPYU","DXD","BNO","ASHR","82843","DMAX","SPXU","USG","02822","BK4570","SDS","HIBL","SPDN","BK7084","SQQQ","USE","82823","DOG","USOI","XLE","CHAU","IVV","BK4097","FGDL","UWM","FTXN","LU0329931090.USD","MVV","BK4588","BAR","BK4007","FNGZ","BK4585","LU0329931173.USD","RGTC","GLD","TNA","VRC","XOP","02843","SPYH","USFR","TWM","ERX","DRLL","SMTG","SPY","UGA","NAPR","COZX","DZZ","LU0531971165.HKD","OUNZ","NJAN","IAU","SH","SMDD","URTY","DGZ","IAUI","GUSH","ALA","ONTX","PSQ","DDG","BK4023","DULL","FXP","KWEB","SRTY","UCO","TQQY","GLDY","LU0823431563.USD","ETNG","URA3","LU0823431647.USD","SGOL","SSO","159945","USL","QQQM","SCO","XES","LU0950373646.USD","FIGG","UDOW","FNGD","QMAR","DRV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657655680","title":"BMO將諾和諾德目標價從45美元上調至47美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655680?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 18:53","pubTimestamp":1786013632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","THNR","BK4588","BK4007","LU1093756168.USD","PPH","BK4585","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","OZEM","NVOX","NVOH","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657685740","title":"諾和諾德中國發布首份可持續發展案例集","url":"https://stock-news.laohu8.com/highlight/detail?id=2657685740","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657685740?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 16:21","pubTimestamp":1786004498,"startTime":"0","endTime":"0","summary":"北京商报讯（记者卓洋）8月6日，诺和诺德中国在北京正式发布《诺言必践——诺和诺德中国2026可持续发展案例集》，并举行了以“诺言必践，和合共生”为主题的发布活动。这是诺和诺德在华发布的首份可持续发展案例集，从创新关怀、协作可及、绿色运营、社会共益四个维度，通过十个真实案例将公司在可持续发展领域取得的积极进展具象化呈现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063833863713.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063833863713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","NVOH","NVOX","OZEM","PPH","BK4599","BK4585","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756168.USD","BK4532","NVO","THNR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657884226","title":"諾和諾德公司：董事會成員、高管及關聯人士買賣諾和諾德公司股票。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657884226","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657884226?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:18","pubTimestamp":1786000709,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756168.USD","BK4532","BK4007","NVOH","PPH","BK4588","NVOX","LU0154236417.USD","LU1093756325.SGD","OZEM","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657500501","title":"「藥王」禮來替爾泊肽上半年大賣277億美元！諾和諾德也靠減重藥扛起大旗","url":"https://stock-news.laohu8.com/highlight/detail?id=2657500501","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657500501?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:28","pubTimestamp":1785997710,"startTime":"0","endTime":"0","summary":"红星资本局8月6日消息，8月5日晚，美国制药公司礼来（LLY.N）发布了2026年二季报，受其GLP-1/GIP双靶点减重降糖药物替尔泊肽销量增长的推动，公司第二季度营收达到229.74亿美元，同比增长48%；上半年总营收为427.73亿美元，同比增长49%。其中，替尔泊肽贡献了约65%的营收，上半年总收入为276.93亿美元，同比增长88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063833799834.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063833799834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0345770308.USD","LU2360106947.USD","LU1035775433.USD","LU1868837136.USD","LU0210536198.USD","LU2237443465.HKD","LU0345770993.USD","IE00BJLML261.HKD","LU0943347566.SGD","LU2237443978.SGD","LU2552382132.HKD","IYH","SG9999015952.SGD","GDOC","LU0158827948.USD","SG9999015986.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","LU0640476718.USD","LU0889565916.HKD","LU0820561818.USD","LU2361044949.HKD","LU1093756168.USD","LU2063271972.USD","LLYZ","LU0466842654.USD","LU1720051108.HKD","LU2237443622.USD","IE0004445239.USD","SGXZ51526630.SGD","LU2112291526.USD","LU0106261372.USD","LU0203202063.USD","BK4585","LU2471134879.HKD","LU0385154629.USD","LU1983299246.USD","IE00BJJMRY28.SGD","LU0079474960.USD","LU0320765059.SGD","LU2462591350.SGD","LU0058720904.USD","SG9999015945.SGD","LU1720051017.SGD","SG9999001176.SGD","LU1623119135.USD","LU0096364046.USD","LU2023250330.USD","BK4533","LU0109394709.USD","BK4581","LU1069344957.HKD","JDOC","LU1917777945.USD","LU2491050071.SGD","LU2168564149.EUR","IE00B775H168.HKD","HRTS","LU1280957306.USD","LU1548497426.USD","LU1988902786.USD","LU1989771016.USD","LU2087625088.SGD","LU2237443549.SGD","LU2237438978.USD","LU2089283258.USD","LU2357305700.SGD","LU0006306889.USD","SG9999015978.USD","LU2491050154.USD","LU0417517546.SGD","LU0353189763.USD","LU0432979614.USD","LU2237443895.HKD","IE00BN29S564.USD","LU2211815571.USD","IXJ","LU0198837287.USD","LU0683600562.USD","IE00BJT1NW94.SGD","LU2168564222.USD","LU2756315664.SGD","LU0353189680.USD","LLYX","LU2462157665.USD","LU0203201768.USD","LU0882574139.USD","LU2168564495.EUR","LU1291159041.SGD","LU1868836914.USD","LU2361044865.SGD","ILDR","LU0787776722.HKD","LU0320765992.SGD","LU0316494557.USD","LU1629891620.HKD","LU1323610961.USD","LU2106854487.HKD","NVOH","LU0471298777.SGD","LU0158827781.USD","LU0456855351.SGD","IE0001KFT4U8.USD","LU0154236417.USD","LU1868836757.USD","IE00BKDWB100.SGD","TMED","LU0672654240.SGD","LU2756315318.SGD","LU2552382215.SGD","LU0097036916.USD","LU0471298694.HKD","LU2552382058.USD","MEDX","TRUH","LU0323591593.USD","LU0882574055.USD","LU0238689110.USD","LU1145028129.USD","XLV","MEDI","SGXZ99366536.SGD","SG9999014914.USD","LU1127390331.HKD","LU1551013342.USD","LU2750360641.GBP","LU2746668974.SGD","LU2750360997.AUD","LU2461242641.AUD","WDNA","LU1061106388.HKD","IE0004445015.USD","LU0061475181.USD","LU0133085943.USD","LU0689472784.USD","LU0820562030.AUD","LU2028103732.USD","LU1804176565.USD","LU0094547139.USD","LU2168563687.JPY","IE00BFTCPJ56.SGD","LLII","LU1979441026.SGD","LU0708995401.HKD","LU1868836591.USD","LU1267930730.SGD","LU2023250504.SGD","BK4516","IE00BWXC8680.SGD","LU2361045086.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU0289739699.SGD","LU2089284900.SGD","SG9999001176.USD","LU2023251221.USD","IE0002141913.USD","LU0964807845.USD","LU2111349929.HKD","FTXH","LU1712237335.SGD","IE00B4R5TH58.HKD","LU0354030511.USD","LU2265009873.SGD","VHT","LU2602419157.SGD","LU0786609619.USD","IE00BJJMRZ35.SGD","NVO","OZEM","IE00BK4W5M84.HKD","GB00BDT5M118.USD","BK4532","LU2417539215.USD","SG9999014898.SGD","LU2471134796.USD","LU1232071149.USD","LU2471134952.CNY","LU2896262040.SGD","LU0109391861.USD","SG9999018857.SGD","MHIP","LU2324357040.USD","SG9999017495.SGD","LU1551013425.SGD","SG9999014906.USD","ELIS","IE0009355771.USD","LU0823434583.USD","SGXZ57979304.SGD","LU1814569148.SGD","LU2264538146.SGD","RXL","LU1057294990.SGD","AGNG","IE00BKVL7J92.USD","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","BK4007","LU0823416689.USD","IE00B1XK9C88.USD","LU2491049909.HKD","SG9999014880.SGD","LU2456880835.USD","LU0225283273.USD","LU0256863811.USD","LU0823434740.USD","IE00B1BXHZ80.USD","LU2089984988.USD","IE00B4JS1V06.HKD","LU1868837300.USD","PPH","CURE","LU2108987350.USD","IHE","LU0266013472.USD","LU1974910355.USD","LU2236285917.USD","LU2468319806.SGD","NVOX","LU1023059063.AUD","LU2271345857.HKD","SG9999018865.SGD","SGXZ31699556.SGD","PJP","LU0354030438.USD","LU1064131342.USD","CANC","LU0174119429.USD","LU2237443382.USD","IE00BJJMRX11.SGD","SG9999013999.USD","LU0234572021.USD","LU2168564065.EUR","IE0005OL40V9.USD","BK4599","LU0820561909.HKD","LU2471134523.USD","LU2213496289.HKD","BK4588","LU2746668461.USD","THNR","FHLC","IE00BKPKM429.USD","LU0122379950.USD","IE00BFSS8Q28.SGD","BK4534","LLY","LU0114720955.EUR","IE00B7KXQ091.USD","SGXZ81514606.USD","LU1366192091.USD","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183741843","title":"從GLP-1先行者到被禮來反超，諾和諾德如何一步步丟掉減重藥領先優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1183741843","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183741843?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 10:33","pubTimestamp":1785983625,"startTime":"0","endTime":"0","summary":"诺和诺德曾凭借Ozempic和Wegovy率先打开GLP-1减重药市场，并一度成为欧洲市值最高的上市公司。但随着产能不足、美国直销渠道布局偏慢以及研发管线对司美格鲁肽依赖较深，先发优势逐渐被削弱。与此同时，礼来凭借Zepbound、Mounjaro以及更丰富的下一代减重药管线实现反超。如今，诺和诺德正在通过组织调整、扩大产能和加快新品商业化重新追赶，而真正决定未来竞争格局的，仍是下一代产品能否重新建立差异化优势。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7ec85b2c1f723f3e05278a0cd609e815","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7ec85b2c1f723f3e05278a0cd609e815"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LLII","NVOX","LLYX","LLY","LLYZ","ELIS","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135937164","title":"金錢語錄：諾和諾德CEO談併購","url":"https://stock-news.laohu8.com/highlight/detail?id=1135937164","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135937164?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 01:49","pubTimestamp":1785952183,"startTime":"0","endTime":"0","summary":"“我不清楚那两家正试图互相接洽的竞争对手究竟有何需求，但我们目前看不到进行变革性并购的必要性。”——这是Ozempic生产商诺和诺德（Novo Nordisk）的首席执行官迈克·杜斯特德（Mike Doustdar）在接受《华尔街日报》采访时所言。此番言论针对的是近期《金融时报》的一篇报道，该报道称阿斯利康（AstraZeneca）与百时美施贵宝（Bristol Myers Squibb）曾就潜在合并事宜进行过商谈。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","IE00BKVL7J92.USD","BK4599","BK4532","NVO","THNR","BK4585","BK4588","OZEM","PPH","IE00BZ1G4Q59.USD","NVOH","BK4007","NVOX","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529184","title":"美銀首席執行官：公司每年為員工支出2.5億美元用於報銷GLP-1減重藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529184","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529184?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 00:44","pubTimestamp":1785948240,"startTime":"0","endTime":"0","summary":"美银首席执行官布莱恩莫伊尼汉周三接受采访称，美国银行每年花费逾 2.5 亿美元，承担员工使用 GLP-1 减重药物的费用。根据莫伊尼汉给出的数据，美银每年为约 21.1 万名员工预留合计超 20 亿美元医疗预算；仅 GLP-1 药物一项，如今就占到全部医疗开支的约 13%。“我们在 GLP-1 药物上投入大约 2.5 亿美元甚至更多，而四五年前这项支出还是零。”这家全美资产规模第二大的银行，同时依托自身庞大的采购体量，与药企、药房福利管理机构谈判压低药价。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-06/doc-inimhyac1066977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","OZEM","NVOX","BK4590","JDOC","NVOH","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657998525","title":"相差百億美元！全球第一大藥王與第二大藥王銷售差距在拉大","url":"https://stock-news.laohu8.com/highlight/detail?id=2657998525","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657998525?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 22:54","pubTimestamp":1785941698,"startTime":"0","endTime":"0","summary":"礼来的替尔泊肽与诺和诺德的司美格鲁肽，在2025年分别成为全球销售额第一大、第二大药物，但这两大GLP-1药物之间的销售额差距在拉大。8月5日晚间，礼来公布的半年报显示，2026年上半年，替尔泊肽（降糖适应证产品Mounjaro和减重适应证产品Zepbound）合计收入达到276.93亿美元，同比大增近88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832918043.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832918043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FHLC","SG9999014880.SGD","HRTS","LU0320765059.SGD","LU2023251221.USD","LU2896262040.SGD","LU0786609619.USD","LU2461242641.AUD","SG9999001176.SGD","LU2023250504.SGD","CANC","LU1804176565.USD","SG9999001176.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0823434740.USD","LU0109391861.USD","LU0323591593.USD","LU0345770993.USD","LU2237443978.SGD","LU2417539215.USD","AGNG","LU0820562030.AUD","LU1868837300.USD","LU0820561909.HKD","BK4585","LU0210536198.USD","LU1989771016.USD","LU1917777945.USD","LU2236285917.USD","LU0345770308.USD","LU2357305700.SGD","LU2168564495.EUR","SG9999013999.USD","GB00BDT5M118.USD","VHT","PJP","LU0820561818.USD","IE00BKPKM429.USD","IE00BK4W5L77.USD","LU1551013342.USD","TMED","SGXZ31699556.SGD","LU2552382058.USD","SG9999014914.USD","LU0174119429.USD","LU2324357040.USD","LU0106261372.USD","LU2271345857.HKD","LU0823416689.USD","IE0009355771.USD","LU1023059063.AUD","LU0471298777.SGD","LU0198837287.USD","LU1267930730.SGD","LU2361044949.HKD","LU0289739699.SGD","LU0354030511.USD","LU1323610961.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU2023250330.USD","IHE","LU2264538146.SGD","LU0097036916.USD","ILDR","LU2361045086.USD","SG9999015945.SGD","LU0079474960.USD","LU1127390331.HKD","LU2168563687.JPY","LU0256863902.USD","IE00BFSS7M15.SGD","LU0122379950.USD","XLV","LU2471134879.HKD","LU0203201768.USD","LU2746668974.SGD","IE00BZ1G4Q59.USD","LU0882574055.USD","LU0432979614.USD","MHIP","GDOC","LU0353189763.USD","LU2111349929.HKD","LU2237443549.SGD","MEDX","OZEM","IE0004445015.USD","PPH","LLII","IE00BJLML261.HKD","MEDI","NVOX","LU1145028129.USD","IE00B7KXQ091.USD","BK4599","LU1291159041.SGD","LU1988902786.USD","LU2211815571.USD","LU2756315318.SGD","THNR","BK4534","LU0256863811.USD","FTXH","LU2237443465.HKD","LU2360106947.USD","IE00B2B36J28.USD","LU0058720904.USD","LU2168564065.EUR","SG9999018865.SGD","LU2471134952.CNY","IE00BKVL7J92.USD","LU0225283273.USD","LU0354030438.USD","LU2168564222.USD","LU2089984988.USD","SG9999014906.USD","LU2491050154.USD","BK4007","LU0234572021.USD","NVOH","LU2471134523.USD","LU1712237335.SGD","LU0094547139.USD","LU0006306889.USD","LU1868837136.USD","SGXZ99366536.SGD","LU2491050071.SGD","BK4516","LU1548497426.USD","LU0943347566.SGD","LU0787776722.HKD","JDOC","LU1366192091.USD","LU1974910355.USD","LU2361044865.SGD","LU0823434583.USD","LU2108987350.USD","LU1064131342.USD","LU2112291526.USD","LU1720051017.SGD","LU2746668461.USD","IE00B4R5TH58.HKD","IE0005OL40V9.USD","LU1232071149.USD","LU1551013425.SGD","LU0158827781.USD","ELIL","LU1280957306.USD","LU2089283258.USD","LU1093756168.USD","LU2087625088.SGD","LU0456855351.SGD","IE00B1BXHZ80.USD","LLY","LU1979441026.SGD","NVO","LU1814569148.SGD","LU0672654240.SGD","LU0466842654.USD","LU0203202063.USD","IXJ","IE00BJJMRY28.SGD","IE0002141913.USD","LU1868836757.USD","LU2106854487.HKD","SG9999017495.SGD","IE00B4JS1V06.HKD","BK4588","LU1069344957.HKD","LU2756315664.SGD","LU0882574139.USD","IE0001KFT4U8.USD","IE00BFSS8Q28.SGD","LLYX","RXL","CURE","LU0353189680.USD","LU1057294990.SGD","LU1623119135.USD","SG9999015952.SGD","BK4532","BK4581","SGXZ51526630.SGD","LU1061106388.HKD","LU0964807845.USD","LU2237438978.USD","LU2750360997.AUD","LU0385154629.USD","LU0061475181.USD","LU1035775433.USD","LU0708995401.HKD","LU2456880835.USD","LU0238689110.USD","LU1720051108.HKD","LU2237443895.HKD","IE00BKDWB100.SGD","LU0417517546.SGD","LU0316494557.USD","LU0154236417.USD","LU2089284900.SGD","IE0004445239.USD","LLYZ","LU1868836914.USD","LU2462157665.USD","LU0889565916.HKD","SG9999015978.USD","LU1868836591.USD","SG9999014898.SGD","LU1093756325.SGD","LU0133085943.USD","LU2028103732.USD","BK4533","LU0683600562.USD","LU2237443622.USD","LU2237443382.USD","LU2471134796.USD","LU0689472784.USD","IE00BN29S564.USD","LU2462591350.SGD","LU2491049909.HKD","LU0109394709.USD","LU2168564149.EUR","IE00BJJMRX11.SGD","LU0096364046.USD","IE00BJJMRZ35.SGD","SG9999015986.USD","IE00B1XK9C88.USD","LU2552382132.HKD","ELIS","LU0471298694.HKD","SG9999018857.SGD","IYH","LU2213496289.HKD","SGXZ57979304.SGD","LU0640476718.USD","LU1629891620.HKD","IE00BK4W5M84.HKD","WDNA","LU0158827948.USD","LU0266013472.USD","LU1983299246.USD","LU0114720955.EUR","LU2552382215.SGD","LU0320765992.SGD","IE00B775H168.HKD","LU2602419157.SGD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","TRUH","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657528844","title":"二季度利潤亮眼股價卻下跌近6% 口服減重藥能撐起諾和諾德的中長期預期嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657528844","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657528844?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:50","pubTimestamp":1785937800,"startTime":"0","endTime":"0","summary":"二季度利润超预期、上调全年指引，却遭遇美股下跌6%；口服GLP-1药物Wegovy商业化取得突破，但下一代核心CagriSema两次头对头败给礼来替尔泊肽。在千亿美元减肥药赛道，诺和诺德正经历从“霸主”到激烈博弈的转变，增长的希望与风险高度集中于口服GLP1这条路线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832855655.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832855655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVO","BK4532","PPH","THNR","BK4588","NVOX","BK4585","IE00BZ1G4Q59.USD","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","NVOH","OZEM","BK4599","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657238540","title":"諾和諾德：海牙法院針對 Ceban 下達臨時禁令。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657238540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657238540?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:44","pubTimestamp":1785937442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","BK4585","PPH","LU1093756325.SGD","OZEM","LU1093756168.USD","THNR","NVOX","NVO","BK4007","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540463","title":"諾和諾德贏得荷蘭法院禁令，保護患者免受未經批准的非法複方司美格魯肽鼻噴霧劑的侵害。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540463","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540463?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:43","pubTimestamp":1785937380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","BK4007","BK4588","NVOH","NVO","LU1093756168.USD","BK4585","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVOX","THNR","LU0154236417.USD","OZEM","BK4532","IE00BKVL7J92.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547441","title":"國產藥加速追趕 減重明星賽道進入「群雄逐鹿」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547441","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935232,"startTime":"0","endTime":"0","summary":"新华财经上海8月5日电2026年，我国“体重管理年”三年行动进入收官之年。当前，全民体重管理意识和技能显著提升，健康生活方式更加普及，部分人群体重异常状况得到改善。体重管理催生了减重经济。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832808212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832808212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["THNR","NVOC","MEDI","NVOX","JDOC","NVOH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657073541","title":"諾和諾德首席執行官：相較於注射劑，口服版 Wegovy 的市場需求之高，讓我們愈發感到意外。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657073541","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657073541?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 20:04","pubTimestamp":1785931485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","THNR","LU0154236417.USD","NVO","OZEM","BK4588","BK4007","BK4532","BK4599","PPH","NVOH","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4585","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657490745","title":"諾和諾德股價下跌6.8%，觸及盤中低點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657490745","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657490745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:43","pubTimestamp":1785930191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","LU0154236417.USD","BK4007","LU1093756168.USD","NVO","OZEM","THNR","NVOX","IE00BKVL7J92.USD","BK4599","BK4588","IE00BZ1G4Q59.USD","NVOH","PPH","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657003549","title":"諾和諾德：目前美國市場索馬魯肽注射劑Wegovy的價格走勢與我們年初啓動定價時一致。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657003549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657003549?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:42","pubTimestamp":1785930157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","BK4585","OZEM","LU1093756168.USD","PPH","IE00BKVL7J92.USD","LU1093756325.SGD","LU0154236417.USD","NVOX","BK4007","NVOH","IE00BZ1G4Q59.USD","BK4532","NVO","BK4599","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657539549","title":"諾和諾德首席財務官表示：我們推進全公司轉型以實現80億丹麥克朗成本節約目標的進度，目前已超前於計劃。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657539549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657539549?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:23","pubTimestamp":1785929036,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756168.USD","BK4532","BK4007","NVOH","PPH","BK4588","NVOX","LU0154236417.USD","LU1093756325.SGD","OZEM","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510014","title":"諾和諾德股價跌勢擴大，目前跌幅已超5%，年初至今累計下跌10%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510014?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:06","pubTimestamp":1785924365,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","BK4588","BK4532","LU0154236417.USD","LU1093756325.SGD","THNR","IE00BKVL7J92.USD","NVOH","NVO","LU1093756168.USD","BK4007","BK4585","NVOX","PPH","IE00BZ1G4Q59.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657107295","title":"諾和諾德(NVO.US)首席執行官：我們將在資本市場日上詳細介紹如何加速早期資產和早期科學的推進。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657107295","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657107295?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:03","pubTimestamp":1785924200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","BK4585","PPH","BK4588","IE00BKVL7J92.USD","THNR","IE00BZ1G4Q59.USD","NVOX","BK4007","NVOH","NVO","OZEM","LU1093756325.SGD","LU0154236417.USD","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}